Clinical Pharmacology

Vanderbilt University has signed an exclusive worldwide license and research collaboration agreement with Neumora Therapeutics, Inc., a clinical-stage biotechnology company pioneering precision medicines for brain diseases through the integration of data science and neuroscience. Read More

Vanderbilt has extended its longest ongoing drug discovery agreement with Osaka, Japan-based Ono Pharmaceutical Co., Ltd., a research and development-oriented pharmaceutical company that is committed to creating innovative medicines in specific areas, through November 2023. Read More

The Fisk-Vanderbilt Master's-to-Ph.D. Bridge Program, which supports minority STEM graduate students, is the subject of a feature story in the Chronicle of Higher Education. Read More

Stanley Hazen, M.D., Ph.D., chair of the Department of Cellular and Molecular Medicine at the Cleveland Clinic Lerner Research Institute, will present the ninth annual Meredith S. and John A. Oates Lectureship in Clinical Pharmacology on Nov. 5. Read More

Can an implanted electrical device like a cardiac pacemaker effectively treat inflammatory diseases like rheumatoid arthritis, including cases that have not responded to drug therapy? Read More

Richard Kim, M.D., former professor of Medicine and clinical pharmacologist at Vanderbilt, will deliver this year’s Grant R. Wilkinson Distinguished Lecture in Clinical Pharmacology at 8 a.m. Thursday, Feb. 27, in 208 Light Hall. Read More

Daniel Levy, M.D., director of the famed Framingham Heart Study, will deliver the seventh annual Meredith S. and John A. Oates Lecture in Clinical Pharmacology on Thursday, Nov. 14. Read More

Eating fava beans increases dopamine in blood and urine, but does not stimulate urinary sodium excretion. Read More

Sekar Kathiresan, M.D., director of Preventive Cardiology at Massachusetts General Hospital, will deliver the ninth annual Grant R. Wilkinson Distinguished Lecture in Clinical Pharmacology on Thursday, April 11. Read More

Cheryl Laffer, M.D., PhD., professor of Medicine, is the new director of the Hypertension Service within the Division of Clinical Pharmacology. Read More

Clinical pharmacologist Jens Titze, M.D., and colleagues have discovered that – in contrast to the prevailing dogma – human sodium levels fluctuate rhythmically with 7-day and monthly cycles. Read More

The main antioxidant compound in green tea increases contractile force in isolated heart cells, suggesting it may be useful in heart failure. Read More

Vanderbilt researchers are investigating the potential benefits of prospective genetic testing for drug safety. Read More

A newer version of an old class of blood pressure lowering drugs may offer advantages for obese patients with metabolic syndrome. Read More

Some patients may need a combo of medications to combat a condition that causes dizziness. Read More